Palantir's $4 Million ARPC Estimate 'Flawed,' Says 'Pharma Bro' Martin Shkreli, But 'I Wouldn't Bet Against Them' - Dow (NYSE:DOW), Palantir Technologies (NASDAQ:PLTR)

1. Martin Shkreli defends Palantir’s growth despite flawed analysis. 2. He projects $1.8 billion cash flow for Palantir by 2025. 3. Competitors like Snowflake pose challenges to Palantir's market dominance. 4. Analyst targets suggest a 46% upside for Palantir’s stock. 5. Palantir joined the S&P 100 index, indicating strong market positioning.